article thumbnail

The Rising Tide of Medical Waste: One Model for Improvement

My Green Doctor

Author: Ishani Majmudar Medical waste is rising tremendously each year, and its implications are not slight. Medical waste is a broad term used to describe any waste products generated at healthcare facilities and includes everything ranging from the disposal of small needles to the energy consumption of radiologic scans. 3 “Each U.S.

Medical 52
article thumbnail

9 Technologies That Will Shape The Future Of Dentistry

The Medical Futurist

Just like in the case of other medical specialties , disruptive innovations will have a huge impact on how dentistry will be practiced and how patients will take care of themselves in the future. Its importance was also highlighted during the COVID-19 crisis to bypass supply chains to meet hospitals’ demands.

Patients 126
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Usage patterns amid hypertension drug recall highlight vulnerability of global supply chains

Medical Xpress

An analysis of global usage patterns of a common hypertension drug following a major recall demonstrates the worldwide impact of contamination at a single manufacturing facility.

article thumbnail

The Wholesaling Prohibition (Potentially) Demystified? FDA’s Take on Supply Chains for Section 503B Outsourcing Facilities

FDA Law

Under section 503B, drugs compounded by an FDA-registered outsourcing facility under the supervision of a licensed pharmacist can qualify for exemptions from FDA approval, labeling with adequate directions for use, and certain drug supply chain security requirements, subject to specific conditions. See 21 U.S.C. Section II at 2.

article thumbnail

Why, Who, When, Where and More: New Draft Guidance on Notifying FDA about Discontinuance or Interruption in Manufacturing

FDA Law

By Véronique Li, Senior Medical Device Regulation Expert & Deborah L. Livornese — On February 6, 2024, FDA issued a draft guidance titled Notifying FDA of a Discontinuance or Interruption in Manufacturing of Finished Products or Active Pharmaceutical Ingredients Under Section 506C of the FD&C Act.

article thumbnail

FDA Takes Another Small Step to Increase Naloxone Access

FDA Law

Because naloxone is a prescription drug, its distribution is subject to the requirements of the Drug Supply Chain Security Act (DSCSA). Because many harm reduction programs don’t have a pharmacy or medical license, wholesale distributors may determine that they are ineligible to purchase prescription drugs.

article thumbnail

Baby Formula Shortages

Georgetown Pediatrics & Family Medicine

Current shortages have been largely caused by supply chain issues and the recent recall of several baby formula products over concerns about contamination. Always mix formula as directed by the manufacturer. Always follow label instructions or those given to you by your pediatrician. Can I make my own baby formula?